The antiviral pill Paxlovid does not significantly reduce COVID-19 hospitalizations in vaccinated older adults, according to ...

The authors compared outcomes among adults just under 70 years who were not prescribed Paxlovid to those who were given the ...

COVID-19 treatment called into question after major study In a nutshell A major study of 1.6 million seniors found that ...

Paxlovid may not decrease the risk for hospitalization or death in older adults vaccinated against COVID-19 as much as ...

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.

A small study on Covid vaccine safety has sparked an online tempest — and highlighted the conundrum faced by some scientists.

A new analysis of health data from Ontario, Canada, suggests that nirmatrelvir-ritonavir (Paxlovid) may provide limited benefit for vaccinated older adults with COVID-19, despite its previously proven ...

Covid hospitalizations were not significantly reduced when adults used the antiviral pill, researchers find. Also, a nationwide study suggests estrogen may play a role in long covid, putting women at ...

Scientists explored the differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccines, and other viral ...

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.